{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:51:42Z","timestamp":1760550702362,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute for General Medicine","doi-asserted-by":"publisher","award":["GM 58448"],"award-info":[{"award-number":["GM 58448"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Department of Anesthesia, Critical Care & Pain Medicine at Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006151","name":"U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004948","name":"Michigan Economic Development Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009953","name":"Michigan Technology Tri-Corridor","doi-asserted-by":"publisher","award":["085P1000817"],"award-info":[{"award-number":["085P1000817"]}],"id":[{"id":"10.13039\/100009953","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejmech.2018.11.019","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T11:56:28Z","timestamp":1542628588000},"page":"810-824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Inhibitable photolabeling by neurosteroid diazirine analog in the \u03b23-Subunit of human hetereopentameric type A GABA receptors"],"prefix":"10.1016","volume":"162","author":[{"given":"Bo","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selwyn S.","family":"Jayakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Titterton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Chiara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel Y.","family":"Savechenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart A.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol S.","family":"Bruzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.11.019_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0165-6147(00)89058-6","article-title":"Neurosteroids and GABAA receptor function","volume":"16","author":"Lambert","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2018.11.019_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pneurobio.2003.09.001","article-title":"Neurosteroid modulation of GABAA receptors","volume":"71","author":"Lambert","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2018.11.019_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2018.11.019_bib4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.11.019_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABAA receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2018.11.019_bib6","first-page":"135","article-title":"Althesin (alphadione, CT 1341): a 'new' induction agent for anesthesia","volume":"29","author":"Cornet","year":"1977","journal-title":"Arch. Chir. Neerl."},{"key":"10.1016\/j.ejmech.2018.11.019_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2165\/00003495-198122010-00002","article-title":"Adverse effects of intravenously administered drugs used in anaesthetic practice","volume":"22","author":"Clarke","year":"1981","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2018.11.019_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/jvp.12312","article-title":"The cardiopulmonary effects and quality of anesthesia after induction with alphaxalone in 2-hydroxypropyl-\u03b2-cyclodextrin in dogs and cats: a systematic review","volume":"39","author":"Chiu","year":"2016","journal-title":"J.\u00a0Vet. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2018.11.019_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nurt.2006.11.003","volume":"4","author":"Nohria","year":"2007","journal-title":"Ganaxolone. Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2018.11.019_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/avj.12223","article-title":"Multicentre, randomised clinical trial evaluating the efficacy and safety of alphaxalone administered to bitches for induction of anaesthesia prior to caesarean section","volume":"92","author":"Metcalfe","year":"2014","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.ejmech.2018.11.019_bib11","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1021\/acs.jmedchem.7b00846","article-title":"Neuroactive steroids. 2. 3\u03b1-Hydroxy-3\u03b2-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5\u03b2-pregnan-20-one (SAGE-217): a clinical next generation neuroactive steroid positive allosteric modulator of the (\u03b3-aminobutyric acid)A receptor","volume":"60","author":"Martinez Botella","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.019_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2007.03.004","article-title":"Mechanisms of neurosteroid interactions with GABA(A) receptors","volume":"116","author":"Akk","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2018.11.019_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/bs.apha.2014.11.005","article-title":"Allosteric ligands and their binding sites define \u03b3-aminobutyric acid (GABA) type A receptor subtypes","volume":"73","author":"Olsen","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.11.019_bib14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1213\/ANE.0000000000001368","article-title":"Mapping general anesthetic sites in heteromeric \u03b3-aminobutyric acid type A receptors reveals a potential for targeting receptor subtypes","volume":"123","author":"Forman","year":"2016","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejmech.2018.11.019_bib15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nsmb.3477","article-title":"Crystal structures of a GABAA-receptor chimera reveal new endogeneous neurosteroid-binding sites","volume":"24","author":"Laverty","year":"2017","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ejmech.2018.11.019_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nsmb.3484","article-title":"Structural basis for GABAA receptor potentiation by neurosteroids","volume":"24","author":"Miller","year":"2017","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ejmech.2018.11.019_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1124\/mol.112.078410","article-title":"Neurosteroid analog photolabeling of a site in the third transmembrane domain of the \u03b23 subunit of the GABA(A) receptor","volume":"82","author":"Chen","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.11.019_bib18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/bi201772m","article-title":"Mapping general anesthetic binding site(s) in human \u03b11\u03b23 \u03b3-aminobutyric acid Type A receptors with [3H]TDBzl-etomidate, a photoreactive etomidate analogue","volume":"51","author":"Chiara","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2018.11.019_bib19","doi-asserted-by":"crossref","first-page":"19343","DOI":"10.1074\/jbc.M113.479725","article-title":"Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human \u03b11\u03b23\u03b32 \u03b3-aminobutyric acid type A (GABAA) receptor","volume":"288","author":"Chiara","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.11.019_bib20","doi-asserted-by":"crossref","first-page":"27456","DOI":"10.1074\/jbc.M114.581728","article-title":"Multiple propofol-binding sites in a \u03b3-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog","volume":"289","author":"Jayakar","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.11.019_bib21","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA117.000359","article-title":"Mapping two neurosteroid-modulatory sites in the prototypic pentameric ligand-gated ion channel GLIC","volume":"293","author":"Cheng","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.11.019_bib22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2017.04.043","article-title":"Synthesis and pharmacological evaluation of neurosteroid photoaffinity ligands","volume":"136","author":"Savechenkov","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.019_bib23","doi-asserted-by":"crossref","first-page":"13196","DOI":"10.1074\/jbc.M213168200","article-title":"Photoaffinity labeling with a neuroactive steroid analogue. 6-azi-pregnanolone labels voltage-dependent anion channel-1 in rat brain","volume":"278","author":"Darbandi-Tonkabon","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.11.019_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jlcr.1558","article-title":"Synthesis of 19-trideuterated ent-testosterone and the GABAA receptor potentiators ent-androsterone and ent-etiocholanolone","volume":"51","author":"Komarapuri","year":"2008","journal-title":"J.\u00a0Label. Compd. Radiopharm."},{"key":"10.1016\/j.ejmech.2018.11.019_bib25","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1016\/S0040-4020(98)01138-7","article-title":"Improved syntheses of aromatase inhibitors and neuroactive steroids efficient oxidations and reductions at key positions for bioactivity","volume":"55","author":"Neves","year":"1999","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.11.019_bib26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1021\/jo0109669","article-title":"Highly chemoselective hydrogenolysis of iodoarenes","volume":"67","author":"Faucher","year":"2002","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.11.019_bib27","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1016\/j.bmcl.2010.09.008","article-title":"Neurosteroid analogues. 15. A comparative study of the anesthetic and GABAergic actions of alphaxalone, \u039416-alphaxalone and their corresponding 17-carbonitrile analogues","volume":"20","author":"Bandyopadhyaya","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.019_bib28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1124\/mol.108.048520","article-title":"Mutations of the GABA-A receptor \u03b11 subunit M1 domain reveal unexpected complexity by modulation by neuroactive steroids","volume":"74","author":"Akk","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.11.019_bib29","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1021\/jm300631e","article-title":"Allyl mTFD-mephobarbital: a potent enantioselective and photoreactive barbiturate general anesthetic","volume":"55","author":"Stewart","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.019_bib30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/ALN.0000000000001978","article-title":"Alphaxalone binds in inner transmembrane \u03b2+-\u03b1--interfaces of \u03b11\u03b23\u03b32 \u03b3-minobutyric acid type A receptors","volume":"128","author":"Ziemba","year":"2018","journal-title":"Anesthesiology"},{"issue":"A","key":"10.1016\/j.ejmech.2018.11.019_bib31","first-page":"22","article-title":"Probing GABAA receptors with inhibitory neurosteroids","volume":"136","author":"Seljeset","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2018.11.019_bib32","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1021\/jm2014925","article-title":"Neurosteroid analogues. Inverted binding orientations of androsterone enantiomers at the steroid potentiation site on \u03b3-aminobutyric acid type A receptors","volume":"55","author":"Krishnan","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.019_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/pro.2401","article-title":"Human \u03b11\u03b23\u03b32L \u03b3-aminobutyric acid type A receptors: high-level production and purification in a functional state","volume":"23","author":"Dostalova","year":"2014","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2018.11.019_bib34","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/pro.456","article-title":"High-level expression and purification of Cys-loop ligand-gated ion channels in a tetracycline-inducible stable mammalian cell line: GABA(A) and serotonin receptors","volume":"19","author":"Dostalova","year":"2010","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2018.11.019_bib35","doi-asserted-by":"crossref","first-page":"11911","DOI":"10.1021\/bi701287a","article-title":"Photoactivated 3-azioctanol irreversibly Desensitizes muscle nicotinic receptors via interactions at aE262","volume":"46","author":"Forman","year":"2007","journal-title":"Biochemistry"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418309772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418309772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:53:11Z","timestamp":1759326791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418309772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"alternative-id":["S0223523418309772"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.019","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitable photolabeling by neurosteroid diazirine analog in the \u03b23-Subunit of human hetereopentameric type A GABA receptors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}